Lilly, Zepbound and LifeMD

Teladoc, LifeMD tie up with Lilly's pharmacy partner to offer Zepbound
(Reuters) -Telehealth firms Teladoc and LifeMD said on Thursday they had signed an agreement with Gifthealth, the pharmacy partner of Eli Lilly's direct-to-consumer site, LillyDirect, to offer patients the weight-loss drug,
LifeMD Integrates With LillyDirect to Offer Access of Single-dose Vials of Zepbound
LifeMD, a virtual primary care services provider, said it is integrating with Gifthealth which will make Lilly's single-dose vials of Zepbound accessible to the company's eligible patients.
LifeMD® Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound
(Nasdaq: LFMD), a leading provider of virtual primary care services, today announced it is integrating with LillyDirect pharmacy provider, Gifthealth, to offer streamlined access of single-dose vials of Lilly’s prescription obesity treatment Zepbound ® (tirzepatide) to eligible LifeMD patients.
Telehealth firms Teladoc, LifeMD tie up with Eli Lilly's pharmacy partner to offer Zepbound
Telehealth firms Teladoc Health and LifeMD said on Thursday they have signed an agreement with Eli Lilly's direct-to-consumer website LillyDirect pharmacy partner, Gifthealth, to offer patients the weight-loss drug,
LifeMD and Teladoc Health partner with LillyDirect pharmacy provider Gifthealth for Zepbound
Healthcare services companies LifeMD (NASDAQ:LFMD) and Teladoc Health (NYSE:TDOC) announced partnerships with Eli Lilly's (NYSE:LLY) direct-to-consumer platform, LillyDirect's pharmacy provider, Gifthealth for Zepbound.
LifeMD announces integration with LillyDirect pharmacy provider
LifeMD (LFMD) announced it is integrating with LillyDirect pharmacy provider, Gifthealth, to offer streamlined access of single-dose vials of
Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...
Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Jefferson Public Radio23h
Consumers can buy Zepbound and Wegovy direct from drugmakers if they pay cash
Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...
ConsumerAffairs2d
Eli Lilly providing lower-priced Zepbound offerings
Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the ...
Verywell Health on MSN5d
Eli Lilly Lowers Cost of Zepbound Vials To Attract People Without Insurance Coverage
Eli Lilly is now offering four doses of Zepbound in self-administration vials. The lower-cost self-pay option targets people ...
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower ...
Managed Healthcare Executive8d
Lilly Lowers Prices of Some Zepbound Doses for Self-Pay Patients
The new lower prices apply to some doses of Zepbound provided in vials but not the autoinjector pens.
Eli Lilly Cuts Price of Weight-Loss Drug Zepbound for Self-Pay Patients
Eli Lilly has lowered the price of its weight-loss drug Zepbound for patients paying out of pocket and introduced two new ...
BioSpace1h
Novo Enters the Ring in Legal Fight Against GLP-1 Compounders
Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...